← The Wire·Consumer·

Hims & Hers raises FY2025 guidance; revenue projects $2.3B, up 59% YoY

Hims & Hers raised guidance, but the headline flags a potential margin reset as GLP-1 offerings reshape its growth economics. With FY2025 revenue of $2.3B, up 59.0% YoY, and a 73.8% gross margin but only a 5.5% net margin, the setup is strong growth against limited bottom-line cushion.

STOCK PHOTO · TIGER LILY

The story

Hims & Hers raised guidance, while the headline highlights pressure on the economics of its GLP-1 business. FY2025 revenue reached $2.3B, up 59.0% YoY, alongside $0.51 diluted EPS.

The company enters the debate with a 73.8% gross margin but a 5.5% net margin, leaving a relatively narrow net-profit base beneath its strong top-line growth. That makes the margin profile, rather than demand alone, central to how the guidance increase is interpreted.

The bull case is the combination of higher guidance and 59.0% YoY revenue growth. The bear case is that GLP-1-related economics could pressure profitability even as sales expand, and the low net margin provides limited evidence of resilience to a reset.

The next read-through is the company's delivered margin performance against the raised guidance, particularly whether gross-margin strength translates into sustained net earnings. The setup presents two sides rather than a clean directional call.

Our read · Fri, Aug 14

HIMS has a mixed setup: raised guidance and 59.0% YoY revenue growth face a margin test with net margin at 5.5%.

Why. The raised guidance and FY2025 revenue of $2.3B, up 59.0% YoY, support the growth case, but the headline's GLP-1 margin-reset concern matters because net margin is only 5.5% despite a 73.8% gross margin. Without forward guidance detail or valuation data, establishing a reliable directional trade remains difficult.

Both cases

The case it holdsRaised guidance and 59.0% YoY revenue growth indicate that demand momentum remains a concrete support for HIMS.
The case it breaksThe margin-reset risk is material because a 5.5% net margin leaves limited bottom-line cushion if GLP-1 growth carries lower economics.

What could change this view: The setup loses its balance if subsequent reporting shows sustained margin expansion alongside the raised guidance, or if GLP-1 economics materially compress profitability.

Hims & Hers Health stock page →
Your side is graded privately against closes after 10 trading days. Research, not advice.

Who reported it · 1

Keep reading

More on HIMS

Hims ends GLP-1 compounding in Lilly deal as shares rally

Latest on the Wire

Australia’s jobless rate hits 5-year high, markets ramp up rate-cut bets for 2027Trump meets Putin and Xi separately ahead of historic three-way talksHyperscale Data warns of $74.8 million gap for Michigan AI projectAlibaba aided China military-linked lab with AI computing technologyMeta pauses plan to give Zuckerberg new shares without losing controlContinue on the Wire →

Top this week

Nvidia allies lobby board to bring back Jensen Huang as CEONvidia chair rules out Huang return as CEO after 75% sales outlookNvidia interim CEO Colette Kress faces first earnings test after HuangNvidia CEO Jensen Huang reportedly resigns as US-China tensions riseNvidia CFO Colette Kress to serve as interim CEO after Jensen Huang
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.

About this report

Reported by Yahoo Finance as Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset?, . Who answers for this

The only report in this record. Closes are licensed end-of-day data from Databento; the move after a story is its first close against the close before it. How this is decided →

Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →